The effectiveness and safety of dorzolamide 2% in addition to multiple topical antiglaucoma medications

Journal of Ocular Pharmacology and Therapeutics

Volumn 15, Issue 4, 1999, Pages 305-312

  Le, Hung H ^a   Chang, Mary R ^a   Cheng, Qi ^a   Lee, David A ^a   Hartenbaum, David ^b  

^a JULES STEIN EYE INSTITUTE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ADRENALIN; APRACLONIDINE; BETAXOLOL; DIPIVEFRINE; DORZOLAMIDE; LATANOPROST; LEVOBUNOLOL; PILOCARPINE; TIMOLOL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EYE TOXICITY; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; TOPICAL DRUG ADMINISTRATION;

EID: 0032839791     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1999.15.305     Document Type: Article

References (17)

1. Lippa, E.A., Carlson, L.E., Ehinger, B., Eriksson, L.O., Finnstrom, K., Holmin, C., Nilsson, S.G., Nyman, K., Raitta, C., Ringvold, A., Tarkkanen, A., Vegge, T., Deasy, D., Holder, D., and Ytteborg, J. Dose response and duration of action of dorzolamide; a topical carbonic anhydrase inhibitor. Arch. Ophthalmol. 110:495-499, 1992.
2. Strahlman, E., Tipping, R., and Voge,l R. The International Dorzolamide Study Group. A double-masked, randomized one year study comparing dorzolamide (Trusopt), timolol, and betaxolol. Arch. Ophthalmol. 113:1009-1016, 1995.
3. Strahlman, E., Tipping, R., and Vogel, R. The Dorzolamide Dose-response Study Group. A six-week dose response study of the ocular hypotensive effect of dorzolamide with a one-year extension. Am. J. Ophthalmol. 122:183-194, 1996.
4. Strahlman, E.R., Vogel, R., Tipping, R., and Clineschmidt, C.M. The Dorzolamide Additivity Study Group. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. Ophthalmology 103:1283-1293, 1996.
5. Keates, E.U. and Stone, R.A. Safety and effectiveness of concomitant administration of dipivefrin and timolol maleate. Am. J. Ophthalmol. 91:243-248, 1981.
6. Berson, F.G. and Epstein, D.L. Separate and combined effects of timolol maleate and acetazolamide in open-angle glaucoma. Am. J. Ophthalmol. 92:788-791, 1981.
7. Dailey, R.A., Brubaker, R.F., and Bourne, W.M. The effects of timolol maleate and acetazolamide on the rate of aqueous formation in normal human subjects. Am. J. Ophthalmol. 93:232-237, 1982.
8. Kass, M.A., Korey, M., Gordon, M., and Becker, B. Timolol and acetazolamide: A study of concurrent administration. Arch. Ophthalmol. 100:941-942, 1982.
9. Cyrlin, M.N., Thomas, J.V., and Epstein, D.L. Additive effect of epinephrine to timolol therapy in primary open-angle glaucoma. Arch. Ophthalmol. 100:414-418, 1982.
10. Korey, M.S., Hodapp, E., Kass, M.A., Goldberg, I., Gordon, M., and Becker, B. Timolol and epinephrine: Long-term evaluation of concurrent administration. Arch. Ophthalmol. 100:742-745, 1982.
11. Tsoy, E. A., Meekins, B.B., and Shields, M.B. Comparison of two treatment schedules for combined timolol and dipivefrin therapy. Am. J. Ophthalmol. 102:320-324, 1986.
12. Allen, R.C. and Epstein, D.L. Additive effect of betaxolol and epinephrine in primary open-angle glaucoma. Arch. Ophthalmol. 104:1178-1184, 1986.
13. David, R., Ober, M., Masi, R., Elman, J., Novack, G.D., Sears, M.L., and Batoosingh, A.L. Treatment of elevated intraocular pressure with concurrent levobunolol and pilocarpine. Can. J. Ophthalmol. 22(4):208-211, 1987.
14. Rulo, A.H., Greve, E.L., and Hoyng, P.E. Additive effect of latanoprost, a prostaglandin F2 alpha analogue, and timolol in patients with elevated intraocular pressure. Br. J. Ophthalmol. 78:899-902, 1994.
15. Stewart, W.C., Ritch, R., Shin, D.H., Lehmann, R.P., Shrader, C.E., and Van Buskirk, E.M. The Apraclonidine Adjunctive Therapy Study Group. The efficacy of apraclonidine as an adjunct to timolol therapy. Arch. Ophthalmol. 113: 287-92, 1995.
16. Robin, A.L., Ritch, R., Shin, D.H., Smythe, B., Mundorf, T., and Lehmann, R. The Apraclonidine Maximum-Tolerated Medical Therapy Study Group. Short-term efficacy of apraclonidine hydrochloride added to maximum-tolerated medical therapy for glaucoma. Am. J. Ophthalmol. 120: 423-432, 1995.
17. Racz, P., Ruzsonyi, M.R., Nagy, Z.T., Gagyi, Z., and Bito, L.Z. Around-the-clock intraocular pressure reduction with once-daily application of latanoprost by itself or in combination with timolol. Arch. Ophthalmol. 114:268-273, 1996.